# Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

> **NCT01245959** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 476 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Docetaxel, cisplatin and fluorouracil
- **RADIATION:** Concurrent chemoradiotherapy

## Key facts

- **NCT ID:** NCT01245959
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2016-04
- **Final completion:** 2018-04
- **Target enrollment:** 476 (ESTIMATED)
- **Last updated:** 2014-02-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01245959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01245959, "Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01245959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*